VRA Fundamental Analysis - VERA BRADLEY INC

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to VRA. VRA was compared to 50 industry peers in the Textiles, Apparel & Luxury Goods industry. VRA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. VRA does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year VRA has reported negative net income.

VRA had a negative operating cash flow in the past year.

In multiple years VRA reported negative net income over the last 5 years.

The reported operating cash flow has been mixed in the past 5 years: VRA reported negative operating cash flow in multiple years.

1.2 Ratios

VRA has a worse Return On Assets (-32.67%) than 88.00% of its industry peers.

With a Return On Equity value of -59.94%, VRA is not doing good in the industry: 80.00% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
ROA	-32.67%
ROE	-59.94%
ROIC	N/A

ROA(3y)-10.99%

ROA(5y)-5.57%

ROE(3y)-18.49%

ROE(5y)-9.46%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

VRA's Gross Margin of 48.89% is in line compared to the rest of the industry. VRA outperforms 52.00% of its industry peers.

In the last couple of years the Gross Margin of VRA has declined.

VRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	48.89%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.8%

GM growth 5Y-1.67%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.

VRA has less shares outstanding than it did 1 year ago.

The number of shares outstanding for VRA has been reduced compared to 5 years ago.

There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

VRA has an Altman-Z score of 2.40. This is not the best score and indicates that VRA is in the grey zone with still only limited risk for bankruptcy at the moment.

VRA has a Altman-Z score of 2.40. This is in the lower half of the industry: VRA underperforms 64.00% of its industry peers.

There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	2.4

ROIC/WACCN/A

WACC9.12%

2.3 Liquidity

VRA has a Current Ratio of 2.28. This indicates that VRA is financially healthy and has no problem in meeting its short term obligations.

VRA has a Current ratio of 2.28. This is in the better half of the industry: VRA outperforms 68.00% of its industry peers.

VRA has a Quick Ratio of 2.28. This is a bad value and indicates that VRA is not financially healthy enough and could expect problems in meeting its short term obligations.

VRA has a worse Quick ratio (0.61) than 88.00% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.28
Quick Ratio	0.61

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

VRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -290.48%.

Looking at the last year, VRA shows a very negative growth in Revenue. The Revenue has decreased by -24.95% in the last year.

Measured over the past years, VRA shows a decrease in Revenue. The Revenue has been decreasing by -5.56% on average per year.

EPS 1Y (TTM)-290.48%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-71.43%

Revenue 1Y (TTM)-24.95%

Revenue growth 3Y-11.71%

Revenue growth 5Y-5.56%

Sales Q2Q%-35.92%

3.2 Future

VRA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 45.22% yearly.

VRA is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -13.28% yearly.

EPS Next Y2.11%

EPS Next 2Y45.22%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-27.55%

Revenue Next 2Y-13.28%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

VRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

The Price/Forward Earnings ratio is 29.28, which means the current valuation is very expensive for VRA.

62.00% of the companies in the same industry are cheaper than VRA, based on the Price/Forward Earnings ratio.

The average S&P500 Price/Forward Earnings ratio is at 22.81. VRA is valued slightly more expensive when compared to this.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	29.28

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

A more expensive valuation may be justified as VRA's earnings are expected to grow with 45.22% in the coming years.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y45.22%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for VRA!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

VERA BRADLEY INC

NASDAQ:VRA (8/22/2025, 8:00:02 PM)

After market: 2.07 0 (0%)

2.07

+0.12 (+6.15%)

Chartmill FA Rating

GICS SectorConsumer Discretionary

GICS IndustryGroupConsumer Durables & Apparel

GICS IndustryTextiles, Apparel & Luxury Goods

Earnings (Last)06-11 2025-06-11/bmo

Earnings (Next)08-27 2025-08-27

Inst Owners69.04%

Inst Owner Change-8.29%

Ins Owners11.17%

Ins Owner Change-13.74%

Market Cap57.82M

Analysts45

Price Target5.61 (171.01%)

Short Float %10.83%

Short Ratio5.36

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)0

Avg EPS beat(2)-377%

Min EPS beat(2)-556.97%

Max EPS beat(2)-197.03%

EPS beat(4)0

Avg EPS beat(4)-330.38%

Min EPS beat(4)-556.97%

Max EPS beat(4)-21.99%

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-6.34%

Min Revenue beat(2)-8.31%

Max Revenue beat(2)-4.37%

Revenue beat(4)0

Avg Revenue beat(4)-10.23%

Min Revenue beat(4)-19.17%

Max Revenue beat(4)-4.37%

Revenue beat(8)0

Avg Revenue beat(8)-8.28%

Revenue beat(12)2

Avg Revenue beat(12)-5.52%

Revenue beat(16)2

Avg Revenue beat(16)-5.68%

PT rev (1m)0%

PT rev (3m)37.5%

EPS NQ rev (1m)0%

EPS NQ rev (3m)-3100%

EPS NY rev (1m)0%

EPS NY rev (3m)-320%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-4.14%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-1.96%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	29.28
P/S	0.17
P/FCF	N/A
P/OCF	N/A
P/B	0.4
P/tB	0.4
EV/EBITDA	N/A

EPS(TTM)-0.8

EYN/A

EPS(NY)0.07

Fwd EY3.42%

FCF(TTM)-1.02

FCFYN/A

OCF(TTM)-0.61

OCFYN/A

SpS12.28

BVpS5.23

TBVpS5.23

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-32.67%
ROE	-59.94%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	48.89%
FCFM	N/A

ROA(3y)-10.99%

ROA(5y)-5.57%

ROE(3y)-18.49%

ROE(5y)-9.46%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-1.8%

GM growth 5Y-1.67%

F-Score4

Asset Turnover1.28

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	37.37%
Cap/Sales	3.32%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.28
Quick Ratio	0.61
Altman-Z	2.4

F-Score4

WACC9.12%

ROIC/WACCN/A

Cap/Depr(3y)37.76%

Cap/Depr(5y)36.59%

Cap/Sales(3y)1.74%

Cap/Sales(5y)1.49%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-290.48%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-71.43%

EPS Next Y2.11%

EPS Next 2Y45.22%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-24.95%

Revenue growth 3Y-11.71%

Revenue growth 5Y-5.56%

Sales Q2Q%-35.92%

Revenue Next Year-27.55%

Revenue Next 2Y-13.28%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-418.45%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-36.94%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-54.28%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-53.19%

OCF growth 3YN/A

OCF growth 5YN/A

VERA BRADLEY INC (VRA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens